title: Baseline serum lipids and renal function in chronic kidney disease patients entering the LORD trial.
abstract: OBJECTIVE
  Previous studies investigating associations between serum lipids and renal disease have generally not taken into account dietary intake or physical activity both known to influence circulating lipids. Furthermore, inclusion of patients on HMG-CoA reductase inhibitors may also have influenced findings due to the pleiotropic effect of this medication. Therefore, the aim of this study is to determine the relationships between serum lipids and renal function in a group of patients not taking lipid-lowering medication and taking into account dietary intake and physical activity.
  
  
  METHODS
  Data from 100 patients enrolled in the Lipid Lowering and Onset of Renal Disease (LORD) trial were used in this study. Patients were included with serum creatinine > 120 micromol/l, and excluded if they were taking lipid-lowering medication. Unadjusted and adjusted relationships were determined between fasting serum lipid concentrations (total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides and total cholesterol/HDL ratio) and measures of renal function (estimated glomerular filtration rate (eGFR), creatinine clearance and serum creatinine) and urinary protein excretion.
  
  
  RESULTS
  Significant (p < 0.05) negative unadjusted relationships were found between lipids (total cholesterol, LDL and HDL cholesterol) and serum creatinine. In support of these findings, logarithmically-transformed lipids (total cholesterol, LDL and HDL cholesterol) were significantly associated with eGFR and creatinine clearance although the effects were of a smaller magnitude. Adjustment for dietary saturated fat intake and physical activity did not substantially change these effects.
  
  
  CONCLUSIONS
  These data do not support the premise that lipids are associated with renal dysfunction in patients with normocholesterolemia.
authors.affiliation: Renal Research Tasmania, Launceston General Hospital, University of Tasmania, Launceston, Tasmania.
authors.forename: R G
authors.initials: RG
authors.lastname: Fassett
authors.forename: M J
authors.initials: MJ
authors.lastname: Ball
authors.forename: I K
authors.initials: IK
authors.lastname: Robertson
authors.forename: D P
authors.initials: DP
authors.lastname: Geraghty
authors.forename: J S
authors.initials: JS
authors.lastname: Coombes
mesh_terms: D001794:Blood Pressure; D003404:Creatinine / Q000097:blood; D004032:Diet; D004311:Double-Blind Method; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000503:physiopathology* / Q000652:urine; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009043:Motor Activity; D011507:Proteinuria
chemical_list: D008055:Lipids; D003404:Creatinine